Tamer Coşkun

7.8k citations

98 papers · 5.5k indexed · 6 hit papers · h-index 32

Impact in

Endocrine and Autonomic Systems top 0.5%
- Regulation of Appetite and Obesity
Endocrinology, Diabetes and Metabolism top 0.5%
- Diabetes Treatment and Management

Papers in

Endocrine and Autonomic Systems 15
- Regulation of Appetite and Obesity 14
Endocrinology, Diabetes and Metabolism 31
- Diabetes Treatment and Management 25

Co-authors: Alexei Kharitonenkov James D. Dunbar Holly A. Bina M. Schneider David E. Moller Yanyun Chen Andrew C. Adams Berrak Ç. Yeğen
Journals: Molecular Metabolism (10 papers)Diabetes (9 papers)Diabetes Obesity and Metabolism (8 papers)American Journal of Physiology-Gastrointestinal and Liver Physiology (7 papers)PLoS ONE (7 papers)
Partner nations: United States Türkiye United Kingdom

In The Last Decade

Tamer Coşkun

97 papers receiving 5.4k citations

Hit Papers

6 papers align trajectories log scale

Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation 2025 · 18 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2025 Cell Metabolism
2023 Diabetes Care
2022 Cell Metabolism
2022 The Lancet
2018 Molecular Metabolism
2008 Endocrinology

Peers

Countries citing papers authored by Tamer Coşkun

Since Specialization

Citations

This map shows the geographic impact of Tamer Coşkun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamer Coşkun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamer Coşkun more than expected).

Fields of papers citing papers by Tamer Coşkun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamer Coşkun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamer Coşkun. The network helps show where Tamer Coşkun may publish in the future.

Co-authors

The 25 scholars most cited alongside Tamer Coşkun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tamer Coşkun Line = papers co-authored together Tamer Coşkun links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Nature Medicine ·Corby K. Martin, Owen Carmichael, Susan Carnell, Robert V. Considine, David A. Kareken, Ulrike Dydak, Richard D. Mattes, David R. Scott, Sergey Shcherbinin, Hiroshi Nishiyama, Alexander J. Knights, Shah Ekramul Alom, Abel Posso Agudelo, Edward Pratt, Axel Haupt, Mark A. Mintun, Diana Otero Svaldi, Zvonko Miličević, Tamer Coşkun	2025	6
2	Decreases in circulating ANGPTL3 /8 concentrations following retatrutide treatment parallel reductions in serum lipids Diabetes Obesity and Metabolism ·Yi Wen, نزيه حسن حسين يونس, Yanzhu Lin, Yan Chen, Ajit Regmi, William C. Roell, Melissa K. Thomas, Mark L. Hartman, Tamer Coşkun, Zvonko Miličević, Axel Haupt, Giacomo Ruotolo, Robert J. Konrad	2025	1
3	Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation Cell Metabolism ·Éric Ravussin, Guillermo Sánchez‐Delgado, Corby K. Martin, Robbie A. Beyl, Frank L. Greenway, Libbey S. O′Farrell, William C. Roell, Srđan Divjak, Jing Li, Hiroshi Nishiyama, Axel Haupt, Edward Pratt, Shweta Urva, Zvonko Miličević, Tamer Coşkun Hit paper breakdown →	2025	18
4	Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysis Diabetes Obesity and Metabolism ·Kieren J. Mather, Andrea Mari, Govinda J. Weerakkody, Tim Heise, J. Hans DeVries, Shweta Urva, Tamer Coşkun, Zvonko Miličević, Axel Haupt, Melissa K. Thomas	2025	7
5	Brainstem BDNF neurons are downstream of GFRAL/GLP1R signalling Nature Communications ·Rim Ragoug, ロバートショック, Солодилова Татьяна Петровна, Wogene Markos, Junzi Pan, Kai-Zhi Hu, 光次松本, Tamer Coşkun, Paul J. Emmerson, Giuseppe D’Agostino, Simon M. Luckman	2024	5
6	Characterization of LY3324954 a long-acting glucagon-receptor agonist Molecular Metabolism ·William C. Roell, Tamer Coşkun, Teayoun Kim, Libbey S. O′Farrell, Jennifer A. Martin, Hayu Almar’atus Sholihah, 文治堀, Michael Ayers, Daniel J. Drucker, Kyle W. Sloop, Agathe Camus, Jorge Alsina‐Fernandez, Kirk M. Habegger	2024	2
7	Effects of Tirzepatide vs Semaglutide on β-Cell Function, Insulin Sensitivity, and Glucose Control During a Meal Test The Journal of Clinical Endocrinology & Metabolism ·Kieren J. Mather, Andrea Mari, Tim Heise, J. Hans DeVries, M M Ecir, Shah Ekramul Alom, Tamer Coşkun, Axel Haupt, Robert J. Heine, Edward Pratt, Melissa K. Thomas, Zvonko Miličević	2024	12
8	Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE∗3-Leiden.CETP mice EBioMedicine ·Zhixiong Ying, DEMBINSKA Izabela, 和弘大串, V M Lariononv, Joost M. Lambooij, Bruno Guigas, Martin Giera, Jan Freark de Boer, Tamer Coşkun, Hongchang Qu, Yanan Wang, Mariëtte R. Boon, Patrick C.N. Rensen, Sander Kooijman	2023	14
9	GIPR Agonism Enhances TZD-Induced Insulin Sensitivity in Obese IR Mice Diabetes ·Michael Kammen, I. Dragičević, Kyla Collins, Xinxin Yu, Brian A. Droz, N. S. Evseyeva, Jessica L. Friedrich, M R De Felice, Debra L. Konkol, Libbey S. O′Farrell, Hana E. Baker, Tamer Coşkun, Philipp E. Scherer, Christine M. Kusminski, Michael E. Christe, Kyle W. Sloop, Ricardo J. Samms	2023	8
10	The novel GIP , GLP ‐1 and glucagon receptor agonist retatrutide delays gastric emptying Diabetes Obesity and Metabolism ·Shweta Urva, Libbey S. O′Farrell, Yu Du, 保志榊原, Anish Thillainathan, Hongchang Qu, Jorge Alsina‐Fernandez, Axel Haupt, Zvonko Miličević, Tamer Coşkun	2023	19
11	Orforglipron ( LY3502970 ), a novel, oral non‐peptide glucagon‐like peptide‐1 receptor agonist: A Phase 1a, blinded, placebo‐controlled, randomized, single‐ and multiple‐ascending‐dose study in healthy participants Diabetes Obesity and Metabolism ·Edward Pratt, Xiaosu Ma, Rong Liu, Deborah A. Robins, Axel Haupt, Tamer Coşkun, Kyle W. Sloop, Charles Benson	2023	23
12	Orforglipron ( LY3502970 ), a novel, oral non‐peptide glucagon‐like peptide‐1 receptor agonist: A Phase 1b, multicentre, blinded, placebo‐controlled, randomized, multiple‐ascending‐dose study in people with type 2 diabetes Diabetes Obesity and Metabolism ·Edward Pratt, Xiaosu Ma, Rong Liu, Deborah A. Robins, Tamer Coşkun, Kyle W. Sloop, Axel Haupt, Charles Benson	2023	34
13	Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation Molecular Metabolism ·Alessia Costa, Minrong Ai, Nicolas Nunn, QI Na-na, 周启超, 光次松本, Lourdes Valencia-Torres, Gabriella Aviello, David J. Hodson, Winston Zamora, Tamer Coşkun, Paul J. Emmerson, Simon M. Luckman, Giuseppe D’Agostino	2021	48
14	The novel dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 ( GLP ‐1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long‐acting GLP ‐1 receptor agonists Diabetes Obesity and Metabolism ·Shweta Urva, Tamer Coşkun, Corina Loghin, Xuewei Cui, Elena Malekkidou, Libbey S. O′Farrell, Daniel A. Briere, Charles Benson, Michael A. Nauck, Axel Haupt	2020	92
15	Dual effects of fibroblast growth factor 21 on hepatic energy metabolism Journal of Endocrinology ·Ricardo J. Samms, Michelle Murphy, Maxine J Fowler, Scott Cooper, 通一丸山, Tamer Coşkun, Andrew C. Adams, Alexei Kharitonenkov, Francis J. P. Ebling, Kostas Tsintzas	2015	15
16	Preproghrelin‐derived Peptide, Obestatin, Fails to Influence Food Intake in Lean or Obese Rodents Obesity ·Guillaume Gourcerol, Tamer Coşkun, Jun-Jie Zhou, John P. Mayer, Mark L. Heiman, Lixin Wang, Mulugeta Million, G Lepeut, Yvette Taché	2007	61
17	FGF‐21/FGF‐21 receptor interaction and activation is determined by βKlotho Journal of Cellular Physiology ·Alexei Kharitonenkov, James D. Dunbar, Holly A. Bina, Stuart W. Bright, Julie S. Moyers, Chen Zhang, Liyun Ding, Radmila Micanovic, 沈玉芬, Michael D. Knierman, John E. Hale, Tamer Coşkun, Armen B. Shanafelt	2007	284
18	Capsaicin-sensitive vagal fibres and 5-HT3-, gastrin releasing peptide- and cholecystokinin A-receptors are involved in distension-induced inhibition of gastric emptying in the rat Regulatory Peptides ·Ayhan Bozkurt, 泰治能川, Hızır Kurtel, İnci̇ Ali̇can, Tamer Coşkun, Berrak Ç. Yeğen	1999	22
19	Inhibitory effects of gastrin releasing peptide on gastric emptying in rats Regulatory Peptides ·Berrak Ç. Yeğen, J. Tice, Tamer Coşkun, Ayhan Bozkurt, Hızır Kurtel, İnci̇ Ali̇can, Graham J. Dockray	1996	15
20	The effect of thermal injury on gastric emptying in rats Burns ·İ. Alican, Tamer Coşkun, Cumhur Yeğen, Kamalapur Snehal, 達嵐梁, Berrak Ç. Yeğen	1995	20

About Tamer Coşkun

Tamer Coşkun is a scholar working on Endocrine and Autonomic Systems, Endocrinology, Diabetes and Metabolism, Gastroenterology, Physiology and Cellular and Molecular Neuroscience, having authored 98 papers that have together received 5.5k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (25 papers), Adipose Tissue and Metabolism (19 papers), Neuropeptides and Animal Physiology (17 papers), Regulation of Appetite and Obesity (14 papers), Fibroblast Growth Factor Research (13 papers), Pancreatic function and diabetes (12 papers), Diet and metabolism studies (10 papers) and Kruppel-like factors research (10 papers). The work is most often cited by research in Endocrine and Autonomic Systems (922 citations), Endocrinology, Diabetes and Metabolism (1.7k citations), Physiology (1.6k citations), Pharmacology (744 citations) and Molecular Biology (2.7k citations). Tamer Coşkun has collaborated with scholars based in United States, Türkiye and United Kingdom. Frequent co-authors include Alexei Kharitonenkov, James D. Dunbar, Holly A. Bina, M. Schneider, David E. Moller, Yanyun Chen, Andrew C. Adams, Berrak Ç. Yeğen, Christine C. Cheng and Axel Haupt. Their work appears in journals such as Molecular Metabolism, Diabetes, Diabetes Obesity and Metabolism, American Journal of Physiology-Gastrointestinal and Liver Physiology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact